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Summary 
The baseline EEG sleep patterns of 10 young depressed patients, 20 patients with anorexia nervosa, 10 
patients with bulimia nervosa, and 10 healthy subjects were found to be indistinguishable, except for an 
increased REM density in the depressed patients. In eating disorder patients, a concomitant major 
depressive episode had no influence on EEG sleep. The results of the cholinergic REM sleep induction test 
revealed a significantly faster induction of REM sleep in the depressed patients when compared with the 
eating disorder patients and the control subjects. This indicates a subthreshold hypersensitivity of the 
REM sleep triggering cholinergic transmitter system in depressives, but not in eating disorder patients. 
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Introduction 
Certain alterations in the EEG sleep patterns of 
patients with major depression are alleged to be 
characteristic of this psychiatric disorder. Besides 
a shallow sleep quality and a reduced amount of 
slow-wave sleep, the most typical alterations are 
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related to rapid eye movement (REM) sleep. The 
time between sleep onset and the beginning of the 
first REM sleep period (REM latency) is shor- 
tened and the density of the rapid eye movements 
during REM sleep (REM density) is increased (for 
overview see Gillin et al., 1984; Reynolds and 
Kupfer, 1987). These altered EEG sleep patterns 
are attributed to neuroendocrine and CNS trans- 
mitter receptor disturbances and are therefore re- 
garded as a biological marker for this disorder. 
The neurochemical model of sleep regulation 
(Hobson et al., 1975, 1986; McCarley, 1982), pro- 
posing a reciprocal interaction of central aminergic 
(REM-‘off’) and choline@ (REM-‘on’) neurons 
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in triggering the cyclic alteration of non-REM and 
REM sleep, assumes a relative overactivity of the 
cholinergic system in depression causing the early 
onset of REM sleep as well as the enhanced REM 
density (for overview see Sitaram et al., 1984). 
This point of view is in accordance with the 
cholinergic-aminergic imbalance theory of affec- 
tive disorders (Janowsky et al., 1972). 
Recent studies investigating the polysomno- 
grams in prepubertal and adolescent depressives, 
however, failed to observe the described EEG 
sleep alterations, i.e., a shortened REM latency 
(Taub et al., 1978; Kupfer et al., 1979; Puig-An- 
tich et al., 1982; Young et al., 1982; Hawkins et 
al., 1985; Goetz et al., 1987; Appelboom-Fondu et 
al., 1988; Kempenears et al., 1988; Kupfer et al., 
1989). Furthermore, in healthy subjects the REM 
latency decreases with increasing age (Feinberg et 
al., 1967; Gillin et al., 1981) and a shortened REM 
latency is reported to occur occasionally in healthy 
seniors (Spiegel, 1981). These observations ques- 
tion the specificity of the EEG sleep patterns 
allegedly characteristic of major depression. On 
the other hand, one might wonder how far the 
altered sleep patterns in major depression may be 
attributed to a ‘premature aging’ of the basic 
neuroendocrine processes organizing sleep pat- 
terns. 
Another aspect in investigating the polysomno- 
grams of young depressed patients is provided by 
the ongoing discussion about the existence of a 
significant biological link between major depres- 
sion and eating disorders, such as anorexia nervosa 
and bulimia nervosa (for overview see Swift et al., 
1986; Strober and Katz, 1987). Several studies 
focused on the EEG sleep pattern in eating dis- 
order patients. A shortened REM latency in at 
least a subgroup of patients with anorexia nervosa 
or bulimia was reported by Neil et al. (1980), Katz 
et al. (1984), and Walsh et al. (1985). In the latter 
two studies, all patients exhibiting a shortened 
REM latency suffered from a significant depres- 
sive mood disturbance. On the other hand, Levy et 
al. (1987, 1988), Hudson et al. (1987) and Lauer et 
al. (1988) found no altered REM sleep patterns in 
anorexic and bulimic patients, regardless of the 
coexistence of a minor or major depression. How- 
ever, the majority of these investigations had the 
disadvantage of not including a comparison group 
of patients with major depression. In an outpa- 
tient study Hudson et al. (1987) reported a lower 
sleep continuity and an increased REM density in 
the depressed patients as compared to the bulimic 
patients. Mean REM latency did not distinguish 
among these groups. 
A further possibility in testing the hypothesis of 
a common biological link between major depres- 
sion and eating disorder is provided by the 
cholinergic REM sleep induction test (RIT) which 
is based on both the cholinergic-aminergic imbal- 
ance theory of depression and the neurochemical 
model of sleep regulation described above. Several 
studies have demonstrated that the REM sleep 
initiating effect of a cholinergic agent (arecoline, 
physostigmine) is significantly more pronounced 
in patients with major depression than in healthy 
volunteers (for overview see Sitaram et al., 1984). 
In eating disorder patients the RIT was performed 
only by Sitaram et al. (1984) using the arecoline 
paradigm. Sixty-six percent of the anorexic pa- 
tients with a concomitant major depression were 
classified as arecoline-supersensitive, whereas only 
12% of the anorexic patients without such a con- 
comitant disorder showed an abnormal REM sleep 
response. 
Spiegel (1984) introduced a further cholinergic 
agent, the spiropiperidyl derivate RS 86 (Sandoz), 
into sleep research. Because of its pharmaco- 
kinetic properties (Palacios et al., 1986) and the 
resulting methodological advantages (Berger et al., 
1989), RS 86 seems to be more suitable than 
physostigmine or arecoline in testing the assump- 
tion of a cholinergic hypersensitivity in major 
depressive disorder. In healthy volunteers, the 
REM sleep inducing properties of RS 86 were 
proved by Spiegel (1984) and Riemann et al. 
(1988). Berger et al. (1985, 1989) demonstrated 
that the effect of RS 86 on REM sleep regulation 
was significantly more pronounced in patients with 
major depression than in patients with other psy- 
chiatric disorders and healthy volunteers, support- 
ing the hypothesis of a functional hypersensitivity 
of the cholinergic system during depression. 
The current comparative study examines the 
polysomnograms of young depressed inpatients, 
of eating disorder inpatients (anorexia nervosa, 
bulimia nervosa), and of healthy subjects in order 
to determine whether there are (a) differences in 
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baseline EEG sleep patterns and (b) differential 
effects of the cholinergic drug RS 86 on the REM 
sleep parameters studied in a subgroup of the 
patient samples and the healthy volunteers. 
Methods 
Subjects 
The following four groups of subjects, matched 
for age and gender distribution, were studied. 
Group 1 consisted of 10 inpatients (eight female, 
two male) with a major depression, melancholic 
subtype (according to DSM-III-R criteria, Ameri- 
can Psychiatric Association, 1987). Ages ranged 
from 18 to 26 years. The mean (k SD) duration of 
the current depressive episode was 3.5 -t 1.4 
months and the number of previous episodes was 
1.9 k 0.9. The patients had no anorexic or bulimic 
symptoms and their body weights ranged from 91 
to 122% of ideal body weight (IBW; according to 
the tables of the Metropolitan Life Insurance 
Company, 1959). 
Group 2 consisted of 20 inpatients (19 female, 
one male) with anorexia nervosa (according to 
both the criteria of Feighner et al., 1972, and the 
broader DSM-III-R criteria) with ages ranging 
from 16 to 27 years. Their body weights ranged 
from 58 to 80% of IBW (mean + SD: 70 k 6%). 
On average, their illness lasted for 3.3 + 2.8 years. 
Nine patients (45%) had a concomitant major 
depressive episode, all of non-melancholic sub- 
type. 
Group 3 consisted of 10 inpatients (all female) 
with bulimia nervosa (according to both the criteria 
of Russell, 1983, and the broader DSM-III-R 
criteria) with ages ranging from 18 to 27 years. 
Their body weights were 85-120s of IBW (mean: 
98.0 + 15.5%). The mean duration of illness was 
6.5 & 2.1 years. Five patients (50%) had a current 
episode of major depression, all of non- 
melancholic subtype. 
Group 4 consisted of 10 normal-weight healthy 
volunteers (nine female, one male; age range 18-27 
years, range of body weights 85-104% of IBW). A 
thorough screening including an extensive semi- 
structured psychiatric interview ensured that they 
were free of physical and personal/family history 
of psychiatric disorders; further, their eating habits 
were ‘normal’ (no dietary schedule, no food selec- 
tion). 
In the patients the diagnosis of major depres- 
sion was assessed by the Composite International 
Diagnostic Interview (CIDI; German version, 
Semler et al., 1987). Severity of depressive symp- 
tomatology was rated by the Inpatient Multidi- 
mensional Psychiatric Scale - second-order factor 
‘depressive symptomatology’ (IMPS; Lorr et al., 
1962; a cut-off value of 15% of the theoretically 
possible maximum score distinguishes well be- 
tween depressed and non-depressed psychiatric 
patients; Berger et al., 1982). 
The medication-free period prior to the poly- 
somnographic investigation was 8-21 days in five 
of the melancholic depressives, at least 6 months 
in the remaining five melancholic depressives, and 
at least 3 months in the eating disorder patients. 
None of the healthy volunteers had ever been 
treated with psychoactive substances. 
Sleep 
All subjects slept for three consecutive nights in 
the sleep research unit of the Max-Planck-Institute 
for Psychiatry, Munich. After two nights, serving 
for adaptation, sleep was recorded between ‘lights 
out’ (23.15 h) and ‘lights on’ (6.30 h) using stan- 
dard procedures (EEG, EOG, EMG). Records 
were then scored visually according to standard 
criteria (Rechtschaffen and Kales, 1968) by two 
experienced raters blind to the subjects’ diagnoses. 
Definitions of sleep measurement have previously 
been described in detail (Lauer et al., 1988). 
Cholinergic REM sleep induction test (RIT) 
Out of the total group of eating disorder pa- 
tients, six anorexic patients (five female, one male; 
age 22.5 + 3.1 years; two patients with a concur- 
rent non-melancholic major depressive episode) 
and six bulimic patients (all female; age 21.5 & 2.7 
years; four patients with a concurrent non- 
melancholic major depressive episode) par- 
ticipated in the RIT. Furthermore, seven patients 
with a major depression (five female, two male; 
age 25.7 f 6.8 years; four were of melancholic 
subtype) and 12 healthy volunteers (seven female, 
five male; age 23.3 + 2.8 years) were investigated 
(the data of five depressives and of seven control 
subjects were selected from another study on the 
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basis of an age under 35 years; Riemann et al., 
1988; Berger et al., 1989). In the depressives and 
the bulimic patients the RIT was performed im- 
mediately after the baseline period. For medical 
reasons, the RIT was performed in the anorexic 
patients after they had reached a body weight of 
at least 80% of IBW (mean IBW: 85.5 &- 5.1%). In 
the eating disorder patients and the control sub- 
jects, the RIT was performed by administering 
orally 1.5 mg RS 86 and placebo, respectively, at 
22.00 h in randomized order. In the depressed 
patients, the drug night was embedded between 
two placebo nights in fixed order (by random 
selection, data analyses include a placebooRS 86 
regime in four depressives, and an RS 86-placebo 
regime in the remaining three depressed patients). 
Sleep was recorded as mentioned above. The sub- 
jects were informed in detail about the possible 
side effects of the drug and written informed 
consent was given. 
Statistics 
Data were analyzed by means of an ANOVA 
(baseline EEG sleep) and a MANOVA (RIT). If 
the variance was inhomogeneous (Bartlett-Box 
F), then the analysis of the respective parameters 
was repeated by means of a Kruskal-Wallis 
ANOVA. Two-sample comparisons were done 
using Student’s t-test; if the variance proved to be 
inhomogeneous, then the corrected form as recom- 
mended by Welch (cited in Pfanzagl, 1962) was 
assessed. The Pearson correlation coefficient 
served to assess correlations. The level of signifi- 
cance was set at 5% (two-tailed). 
Results 
As expected, the anorexic patients had a lower 
body weight than the other three groups (F = 35.5, 
df= 3, P -C 0.001). The depressive symptomatol- 
ogy (IMPS) was most severe in the melancholic 
depressives (IMPS: 56.4% f 13.3% of maximum 
value; F= 37.5, df= 2, P -C 0.001). The patients 
with bulimia nervosa showed a more depressed 
mood than the patients with anorexia nervosa 
(IMPS: 29.7% _t 8.0% of maximum value vs. 19.5% 
k 8.4% of maximum value; t = 3.2, df = 28, P < 
0.01). 
Baseline EEG sleep 
Measurements of sleep continuity, sleep archi- 
tecture and REM latency did not distinguish be- 
tween the three patient samples and the healthy 
controls (a detailed description of data obtained 
in the anorexic and bulimic patients is given in 
Lauer et al., 1988). The only sleep parameters 
significantly differing between the groups were the 
REM density of the first REM period (F = 3.22, 
df = 3, P < 0.05) and the mean REM density (F 
= 6.37, df = 3, P < 0.001). Both measurements 
were highest in the patients with melancholic de- 
pression. 
In a further analysis the sample of the eating 
disorder patients was dichotomized according to 
the presence/absence of a concurrent DSM-III-R 
diagnosis of a major depressive episode. The re- 
sults obtained are presented in Table 1. Depres- 
sive symptomatology (as measured by the IMPS) 
was most severe in the melancholic depressives; 
the eating disorder patients with a concomitant 
major depression were rated to be less depressed 
than the melancholic depressives (t = 5.6, df = 22, 
P < 0.001) but only tended to display a more 
deteriorated mood when compared with the eating 
disorder patients without such an additional 
DSM-III-R diagnosis (t = 1.6, df = 28, P < 0.12). 
Again, sleep continuity and sleep architecture 
did not differ between the groups. The mean 
REM latency was shortest in the melancholic de- 
pressed patients (Fig. 1). This observation, how- 
ever, was not confirmed by statistical analysis 
(Table 1). Calculating the frequencies of shortened 
REM latency (< 45 n-tin; indicated by the dotted 
line in Fig. 1) it was found that the melancholic 
depressives exhibited a shortened REM latency 
more often than the other three groups (x2 = 9.69, 
df = 3, P < 0.025). Again, the REM density of the 
first REM period and the mean REM density 
were significantly increased in the melancholic 
depressives when compared to the eating disorder 
groups (t > 2.5, P < 0.05). In comparison with the 
control subjects, the REM density of the 
melancholic depressives only tended to be in- 
creased (first REM density; t = 1.76, df = 18, P < 
0.10; mean REM density: t = 1.98, df = 18, P < 
0.07). 
Dichotomizing the eating disorder group on the 
basis of severity of depressive symptomatology 
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TABLE 1 
STATISTICAL RESULTS (MEAN+ SD, ANOVA) OF CLINICAL CHARACTERISTICS AND SLEEP PARAMETERS IN 
PATIENTS WITH MAJOR DEPRESSION, EATING DISORDER PATIENTS WITH AND WITHOUT A CONCOMITANT 
MAJOR DEPRESSION, AND HEALTHY SUBJECTS 
Depression 
(n =lO) 
Age (years) 
Body weight (of IBW) 
Depressive symptomatology 
(IMPS; % max. value) 
Sleep continuity 
Sleep period time (SPT, min) 
Sleep efficiency (I%) 
Sleep onset latency 
Intermittent wake time (mm) 
Sleep architecture 
Slow-wave sleep (%SPI) 
REM sleep (SSPT) 
REM sleep 
REM latency (min) 
Duration of first REM period 
@-tin) 
First REM density (Sg) 
Mean REM density (Sg) 
22.7+ 2.2 
103.4* 12.2 
51.3 f 12.5 
416.5 * 33.2 
89.2* 9.2 
21.1+ 15.9 
24.3 f45.0 
21.2+ 8.6 
22.6% 8.5 
56.4 I 29.8 
17.8 i 19.5 
31.1 i. 13.0 
41.2i 9.7 
Eating disorder Control ANOVA 
Depressed a Non-depressed 
subjects 
(n =14) (n =16) 
(n =lO) 
21.9+ 3.1 
19.4 + 16.5 
29.7* 8.0 
419.0 f 24.8 
90.1+ 6.7 
19.6k14.6 
19.8 _+ 20.6 
23.0+ 10.1 
18.3+ 5.7 
76.8 I 24.1 
12.42 8.1 
19.3j, 9.3 
29.1 f 9.7 
21.6* 3.4 
79.6 i 17.3 
19.5* 8.4 
399.5 k 29.6 
88.8* 6.9 
15.3* 15.1 
15.7k20.1 
16.7+ 8.4 
20.7+ 6.8 
78.3 f 66.2 
19.5 i 19.5 
20.4i 8.9 
24.2 k 7.6 
23.15 3.1 
96.0* 5.9 
413.75 17.0 
93.2f 4.2 
19.0 f 10.6 
7.8kll.O 
19.6+ 7.6 
19.4+ 3.7 
72.0+ 31.5 
14.6i 8.6 
22.4i 8.5 
32.2 + 10.5 
F(3) = 0.62 
F(3) = 8.18 P < 0.001 
F(2) = 30.65 P < 0.001 
F(3) = 1.55 
F(3) = 0.94 
F(3) = 0.40 
F(3) = 0.75 
F(3) = 1.36 
F(3) = 0.94 
F(3) = 0.58 
F(3) = 0.61 
F(3) = 3.24 P i 0.05 
F(3) = 7.18 P < 0.001 
a Concomitant major depression according to DSM-III-R criteria 
t&j% Control 
Depress~m wg Dsordw Sub&s 
d non-d 
min 
'300.5 
P 
Fig. 1. REM latency during baseline night in 10 patients with 
major depression, melancholic subtype, 14 eating disorder pa- 
tients with a concomitant DSM-III-R diagnosis of a major 
depression (d), 16 non-depressed eating disorder patients (non- 
d), and 10 healthy volunteers. The bars represent the means. 
The dotted line indicates the cut-off value (45 min) of REM 
latency. 
(using a cut-off IMPS value of 15% of maximum 
value) no significant differences were found be- 
tween these two groups. When compared to the 
melancholic depressives, both eating disorder sam- 
ples showed a significantly lower REM density 
(t > 2.50, P < 0.05). 
Re-examining these observations by means of 
non-parametric methods (Kruskal-Wallis ANO- 
VA) the results did not change. 
No significant correlation coefficients were ob- 
served between sleep measurements and severity 
of depressive symptomatology or body weight in 
any of the groups. Age was negatively correlated 
with the relative amount of slow-wave sleep in the 
eating disorder patients without a concomitant 
depressive episode (r = - 0.64, P < 0.01); in all 
other samples this association approximated the 
level of significance (P < 0.10). Further, age was 
negatively associated with REM latency in the 
melancholic depressives (r = - 0.66, P < 0.05). 
Cholinergic REM sleep induction test 
Table 2 summarizes the descriptive statistics of 
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TABLE 2A 
STATISTICAL RESULTS (MEAN + SD; REPEATED-MEASUREMENT ANALYSIS) OF EEG SLEEP PARAMETERS DUR- 
ING THE PLACEBO AND DRUG (RS 86) NIGHTS IN PATIENTS WITH MAJOR DEPRESSION, EATING DISORDER 
PATIENTS AND CONTROL SUBJECTS 
Eating disorder (n = 12) 
Placebo RS 86 
Sleep efficiency (W) 
Slow-wave sleep (OSPT) 
REM sleep (%SPT) 
REM latency (min) 
First REM period (min) 
First REM density (S) 
Mean REM density (W) 
87.5 + 10.9 
22.7k 8.1 
20.3k 4.2 
75.2 + 22.2 
14.3+ 8.2 
21.7+ 7.1 
28.9k 4.2 
87.3k11.3 
10.9& 9.8 *** 
22.Ok 5.2 
53.3 + 22.5 * * 
19.9k 13.8 
26.4* 11.9 
29.0 f 10.2 
Depression (n = 7) 
Placebo RS 86 
86.7k21.0 85.4k 10.4 
13.8f 8.7 9.9* 7.7 
20.5& 2.9 23.5+ 5.5 * 
91.6 + 34.4 17.5 k 25.8 * * * 
10.7* 7.3 15.5 * 11.4 
28.8 f 18.8 46.6 + 19.7 * * * 
36.6 + 17.7 41.Ok18.4 
Control subjects (n = 12) 
Placebo 
-94.0* 4.0 
19.6k 7.7 
18.7k 2.4 
72.8 f 27.6 
12.2+ 9.5 
26.2 i 13.4 
34.0 + 12.2 
RS 86 
92.3+ 3.3 
14.5* 7.7 * 
21.6+ 3.1 * 
54.5 * 19.3 * 
17.7 k 12.7 
26.0-t 11.6 
33.6 _t 10.2 
Repeated-measurement analysis: * P < 0.05; * * P < 0.01; * * * P -c 0.001 
TABLE 2B 
MAIN EFFECTS (MANOVA) 
Diagnosis Treatment Interaction 
F(2) I-’ F(1) P F(2) P 
Sleep efficiency 
(S) 1.52 0.54 0.11 
Slow-wave sleep 
(%SPT) 1.24 25.84 < 0.001 3.52 < 0.05 
REM sleep 
(%SPT) 0.66 12.43 < 0.005 0.37 
REM latency 
(min) 0.56 57.16 i 0.001 10.77 < 0.001 
First REM period 
(min) 0.48 4.80 < 0.05 0.01 
First REM density 
(S) 2.92 < 0.07 13.08 < 0.005 5.96 < 0.01 
Mean REM density 
(49) 1.70 0.9 20.99 
the placebo and the drug night as well as the 
results of the MANOVA (Table 2B) and the re- 
peated-measurement analysis (Table 2A). During 
the placebo night no significant group effect was 
observed, replicating the results obtained during 
the baseline period. After administering RS 86 
(treatment effects) the relative amount of slow- 
wave sleep (SWS) was reduced, whereas the rela- 
tive amount of REM sleep was increased. Mean 
REM latency was highly significantly shortened 
during the drug night and both the duration and 
the REM density of the first REM period were 
increased. Interaction effects (group x treatment) 
were observed with regard to the relative amount 
of SWS as well as to REM latency and the first 
REM density. 
In order to analyze the differential effects of 
RS 86 on sleep patterns in more detail, a 
repeated-measurement analysis was computed 
(within-group test: placebo vs. RS 86). During the 
drug night, the relative amount of SWS was re- 
duced in the eating disorder patients and the 
control subjects, but not in the depressed patients. 
The increase of the relative amount of REM sleep 
during the drug night was proved in the depres- 
sives and the control subjects. REM latency was 
significantly shortened in each sample. This effect 
of RS 86, however, was significantly more pro- 
nounced in the depressives than in the eating 
disorder patients and the control subjects (F = 
7.38, df= 2, P -c 0.005; see Fig. 2). In the latter 
two samples mean REM latencies were similar. 
Five (72%) of the seven depressed patients, but 
only one eating disorder patient (8%; a patient 
with bulimia nervosa not suffering from a con- 
comitant major depressive episode), displayed a 
sleep onset REM period (REM latency < 20 min; 
see Fig. 2). The REM density of the first REM 
period was significantly increased in the depressed 
patients when compared to the eating disorder 
patients and the control subjects (F = 5.72. df= 2, 
P < 0.01). 
Comparing the eating disorder patients with 
and without a concomitant major depressive epi- 
sode, no differential effect was found. In particu- 
lar, mean REM latencies of these two samples 
were similar during the placebo night (70 + 7 vs. 
min 
140 
120 
100 
20 
0 
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Major Depression Eating Disorder Control Sub- 
PCODOl 
. 
Interaction : F= 10,8, p c 0,001 
0 p < 0.0 1 
\ 0 
P RS 86 P Rs86 P RS06 
0 
\ 
p < 0.05 
l major depression o non-depressed 
Fig. 2. REM latency during the placebo (P) and RS 86 nights in seven patients with major depression, 12 eating disorder patients, 
and 12 healthy volunteers. The bars indicate the means. 
81 f 31 min; P < 0.65) as well as during the drug 
night (50 + 7 vs. 56 f 32 min; P < 0.75). 
Discussion 
The one-night baseline EEG sleep of patients 
with melancholic depression, patients with eating 
disorder, and healthy subjects was found to be by 
and large indistinguishable. The only sleep mea- 
surement differentiating among the groups was 
the REM density which was increased in the de- 
pressed patients. Contrary to expectation, mean 
REM latency - one of the most robust biological 
markers for major depression - did not differ 
among the groups investigated. These observa- 
tions did not change when dichotomizing the eat- 
ing disorder patients according to the presence/ 
absence of a concomitant major depressive epi- 
sode or on the basis of severity of depressive 
symptomatology. The patients with a major de- 
pression, however, were significantly more sensi- 
tive to cholinergic REM induction than the eating 
disorder patients and the healthy volunteers. 
The observation of similar baseline EEG sleep 
measurements in patients with a major depression, 
melancholic subtype, and in healthy subjects seems 
to be not in line with the EEG sleep alterations 
often reported in this disorder (for overview see 
Gillin et al., 1984; Reynolds and Kupfer, 1987). 
Due to the relatively small sample sizes in the 
present study one might view these ‘negative’ find- 
ings as a type II statistical error. However, one 
also has to take into consideration that in the 
present study, the oldest patient was 27 years, 
whereas the depressed patients in the majority of 
published investigations were middle-aged. Several 
recent polysomnographic studies performed in 
juvenile and adolescent depressives give evidence 
that in the majority of these patients the allegedly 
typical REM sleep alterations are not present (e.g., 
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Taub et al., 1978; Hawkins et al., 1985; Goetz et 
al., 1987; Appelboom-Fondu et al., 1988; Kempe- 
naers et al., 1988; Kupfer et al., 1989). In a 
retrospective analysis of the EEG sleep patterns of 
70 depressed inpatients and of 40 healthy volun- 
teers, ranging in age from 18 to 65 years, we 
demonstrated that the polysomnograms of the de- 
pressives and the control subjects were by and 
large indistinguishable up to the middle of the 
fourth decade of life (Lauer et al., 1987). In ad- 
dition, several authors reported a close link be- 
tween increasing age and EEG sleep alterations in 
major depression indicating a ‘premature aging’ of 
the sleep regulating mechanisms in this disorder 
(Ulrich et al., 1980; Gillin et al., 1981; Kupfer et 
al., 1986; Lauer et al., in preparation). The similar- 
ity of the EEG sleep patterns in the depressives 
and in the healthy volunteers observed in the 
present study, therefore, might be mainly due to 
the young age of the patients, thus disguising the 
proposed depression-associated disturbances in the 
basic processes regulating sleep, i.e., REM sleep. 
Contrasting the polysomnograms of patients 
with anorexia nervosa, with bulimia nervosa, and 
with major depression, no significant differences 
in sleep parameters were observed. The only ex- 
ception was a significantly increased REM density 
in the patients with major depression. These ob- 
servations are in line with the findings of Hudson 
et al. (1987) obtained in outpatients with bulimia 
and major depression. Since the issue of EEG 
sleep patterns in the patients with anorexia nervosa 
and bulimia nervosa as well as in the healthy 
subjects was recently addressed in detail by us 
(Lauer et al., 1988) it will not be a subject of the 
present paper. In regard to ‘depression-like’ sleep 
alterations in eating disorder patients, particularly 
of REM sleep, the present study yielded com- 
pletely ‘negative’ findings. Neither the dichoto- 
mizing of the samples according to operational 
diagnostic criteria (concomitant major depressive 
episode) nor according to the observer ratings 
(severity of depressive symptomatology) led to 
significant differences in EEG sleep measurements 
within the eating disorder groups. Furthermore, 
the sleep patterns of the dichotomized patient 
samples were quite similar to that found in the 
control subjects. Finally, the REM density - the 
only EEG sleep parameter which tended to be 
increased in the patients with major depression 
when compared to the healthy volunteers ~ was 
significantly lower in the eating disorder patients 
than in the patients with major depression. The 
failure to observe a reduced REM latency in the 
eating disorder patients is in line with the findings 
of Levy et al. (1987, 1988) and Hudson et al. 
(1987). Others, however, reported a shortened 
REM latency in at least a subgroup of anorexic 
and bulimic patients (Neil et al., 1980; Katz et al., 
1984; Walsh et al., 1985). Besides some method- 
ological shortcomings of the latter three studies 
(for discussion see Lauer et al., 1988) one also has 
to consider the concept of a ‘biological scar’ to 
explain the discrepancies in results. This concept 
attributes the EEG sleep alterations in major de- 
pression to disturbances in sleep regulating sys- 
tems irreversibly acquired during a previous de- 
pressive episode (Holsboer, 1988). Unfortunately, 
neither Katz et al. (1984) nor Walsh et al. (1985) 
gave information about the occurrence of lifetime 
diagnoses of major depression in the patients in- 
vestigated. In the present eating disorder sample, 
four patients displayed a previous episode of major 
depression, their REM latencies during the acute 
period of eating disorder, however, were well 
within the norm. Not only this observation but 
also several further studies reporting a normaliza- 
tion of EEG sleep patterns in remitted depressives 
(Kerkhofs et al., 1985; Knowles et al., 1986; Schulz, 
1988; Riemann et al., 1989) do not support the 
concept of a biological scar. On the other hand, 
Rush et al. (1986) and Steiger et al. (1989) ob- 
served a continuation of altered EEG sleep pat- 
terns in remitted depressed patients favoring this 
hypothesis. 
Whereas on average the baseline EEG sleep in 
the groups investigated was by and large indis- 
tinguishable, there were some - at least discrete - 
indices of altered sleep patterns in the young 
melancholic depressives. In this patient sample a 
shortened REM latency was found more often - 
although the mean REM latency did not differ - 
than in the eating disorder patients and in the 
control subjects. In addition, the melancholic de- 
pressives tended to display an increased REM 
density when compared to the healthy subjects; in 
comparison to the eating disorder patients, this 
difference was statistically significant. In other 
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words, some young depressed patients exhibited 
REM sleep alterations typical of depression and 
others did not. In some studies investigating 
juvenile and adolescent depressives the character- 
istic REM sleep abnormalities (Lahmeyer et al., 
1983; Emslie et al., 1987) or at least an increased 
REM density (Cashman et al., 1986) were re- 
ported. These observations suggest that age is not 
the only determining factor in the occurrence of 
the altered sleep patterns in major depression. 
According to the cholinergic-aminergic imbalance 
theory of depression (Janowsky et al., 1972) and 
the neurochemical model of sleep regulation (Mc- 
Carley, 1982; Hobson et al., 1986), it seems plausi- 
ble to assume in young depressives too an in- 
creased - but still subthreshold - functional activ- 
ity of the REM sleep triggering cholinergic trans- 
mitter system. This assumption is supported by 
the observation that the sensitivity of young 
depressed patients to cholinergic REM induction 
by RS 86 seems to be similar to that of elderly 
depressives, although the baseline (placebo) REM 
latencies in the young depressives were found to 
be significantly longer than in the elderly patients 
(Lauer et al., 1987; Berger et al., 1989). 
Observing a comparable REM sleep initiating 
effect of RS 86 in eating disorder patients would 
favor the proposed biological link between eating 
disorder and major depression. However, the re- 
sults of the present study do not support such an 
assumption. In all samples, a significant shorten- 
ing of REM latency was observed after the admin- 
istration of RS 86. This effect was, however, clearly 
much more marked in the patients with a major 
depression. In the eating disorder patients (with or 
without a concomitant major depressive episode) 
and the healthy volunteers the shortening of REM 
latency was similar, indicating no differences be- 
tween these groups in the sensitivity of the REM- 
regulating system to a cholinergic stimulus. 
Sitaram et al. (1984) on the other hand, reported 
a significantly higher proportion of RIT re- 
sponders in anorexic patients with a current major 
depressive episode than in anorexics without such 
an additional diagnosis. Differences in methods 
(Sitaram et al. applied the arecoline paradigm; in 
the present study the RS 86 regime was used) and 
in the patient selection criteria (the depressed 
anorexics in the study by Sitaram et al. all had a 
personal and/or family history of affective illness; 
in the present RIT only one bulimic patient had a 
lifetime diagnosis of major depression) may con- 
tribute mainly to the differing observations. 
On the basis of our findings, we conclude that 
by means of polysomnographic measurements 
during baseline conditions a differentiation is 
hardly possible between young depressed patients 
or, more generally, among young psychiatric pa- 
tients and healthy volunteers. Nevertheless, the 
relative overactivity of the cholinergic transmitter 
system held responsible for the REM sleep dysreg- 
ulation in depression seems to be present in young 
depressives too, but at a subthreshold level not 
obviously affecting baseline EEG sleep. This 
threshold, however, can be overcome by adminis- 
tering a cholinergic agent, i.e., RS 86. On the other 
hand, in eating disorder patients, with or without 
a concurrent major depressive episode, no hint 
was found of an increased sensitivity of the central 
cholinergic transmitter system, contradicting the 
assumption of a significant biological link between 
eating disorder and major depression. 
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